Wegovy Pill Still Dominating GLP-1 Market, Analysts Say
Wegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
Focusing on short term investment goals can yield quick financial returns. Discover the right timing for your investment strategy.
27,474 articlesWegovy continues to lead the U.S. GLP-1 market despite Eli Lilly's Foundayo launch. Investors are weighing uptake, pa...
An aging couple watched a life savings evaporate in a single, fear-driven moment. This is how a fake family emergency...
Two industry giants released mixed Q1 results, highlighting divergent paths for July. Lockheed Martin stays mission-f...
Cardano’s ADA retreated about 11% month-to-date, pushing buyers to defend a trio of critical supports. Analysts outli...
Murphy Oil has surged about 48% in the past year, with shares trading near a 52-week high as Vietnam offshore project...
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
In a renewed push to accumulate, Strategy added 1,550 BTC for about $101 million in early June, boosting holdings to ...
A new bipartisan proposal would create a formal commission to study the long-term finances of Social Security and Med...
Microsoft shifts core apps to its MAI system, pressuring margins while Google leans on in‑house silicon and Gemini. A...
A single cloud ETF has become the dominant vehicle for exposure as cloud stocks swing in 2026, prompting a shift away...
NVIDIA leads the AI hardware wave while Palantir gains momentum on enterprise software. Investors debate which stock ...
wlfi holders dump 1.8b tokens in a record profit event on May 18, underscoring a sharp shift in the token’s owner bas...